Information Library
News Items - Oncology
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
QUINTILES ANNOUNCES STRATEGIC ALLIANCE TO ADVANCE EISAI’S ONCOLOGY PIPELINE
October 30, 2009 - Quintiles announced a strategic alliance with leading global pharmaceutical company Eisai Co. Ltd. (Tokyo, Japan) to develop six potential oncology products in Eisai’s R&D pipeline. -
QUINTILES ANNOUNCES NEW GHANA OFFICE
June 16, 2009 - To improve efficiency and expand capacity to monitor the growing number of clinical studies being conducted in Western Sub-Saharan Africa, Quintiles today announced the opening of a new office in Accra, Ghana. -
QUINTILES ADVANCES CANCER TREATMENT THROUGH NEW GENETIC TESTS
May 26, 2009 – Targeted Molecular Diagnostics (TMD), a Quintiles Central Laboratory, announces the availability of two new laboratory tests used to develop more effective cancer treatments. -
QUINTILES GLOBAL CENTRAL LABORATORY NETWORK SETS NEW STANDARD
March 11, 2009 – Quintiles Transnational Corp. has the largest CAP-accredited central laboratory network in the world - setting a standard for patient safety and faster drug development. -
QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDIATION
March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network. -
QUINTILES MOVES TO SPEED DEVELOPMENT OF CANCER THERAPIES
January 15, 2009 - Quintiles Transnational Corp. announced that it has adopted “common contract language” to significantly reduce contract negotiation time, and shorten the drug testing process.
Page 1 of 1 (6 items)